Skip to main content

Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention

Ye T, Xu W, Barrachina MN, Lyu P, Antoszewski M, della Volpe L, Guo C, Lee AJ, Theardy MS, Shelton SD, Wahlster L, Caulier A, Messa L, Poeschla M, Agarwal G, Mitra R, Schmaier AA, Weissman JS, Machlus KR, Sankaran VG
bioRxiv 2026.03.27.714536; doi: 10.64898/2026.03.27.714536 (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
258404IVT-CRISPRiTemplate for in vitro transcription of CRISPRi
258405IVT-CRISPRoffTemplate for in vitro transcription of CRISPRoff
258406IVT-CHARMTemplate for in vitro transcription of CHARM
258407IVT-CHARM-Template for in vitro transcription of CHARM without the KRAB domain
258408IVT-TET-dCas9Template for in vitro transcription of TET-dCas9

Antibodies from Article